Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 12Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 1332Carcinoma, Hepatocellular 784Stomach Neoplasms 721Pancreatic Neoplasms 704Colonic Neoplasms 534Rectal Neoplasms 472Esophageal Neoplasms 423Liver Neoplasms 320Neoplasms 264Breast Neoplasms 220Lung Neoplasms 188Gastrointestinal Neoplasms 164Cholangiocarcinoma 150Barrett Esophagus 116Prostatic Neoplasms 107Neoplasm Metastasis 105Ovarian Neoplasms 89Carcinoma, Non-Small-Cell Lung 80Anus Neoplasms 77Melanoma 72Esophageal Squamous Cell Carcinoma 71Head and Neck Neoplasms 70Disease 70Gastrointestinal Stromal Tumors 67Colorectal Neoplasms, Hereditary Nonpolyposis 67Biliary Tract Neoplasms 67Liver Cirrhosis 60Gallbladder Neoplasms 58Recurrence 57Uterine Cervical Neoplasms 56

Interventions

trastuzumab deruxtecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × HER2-positive Gastric Cancer × Gastrointestinal × Clear all
NCT06846996 2025-07-08

RECOVER

Daiichi Sankyo

Recruiting
260 enrolled
Gastrointestinal

HER2-positive Gastric Cancer

NCT04520295 2020-08-20

ctDNA Screening in Advanced HER2 Positive Gastric Cancer

Ruijin Hospital

Unknown
100 enrolled
Gastrointestinal

HER2-positive Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡